An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) will release its 2023 fourth quarter earnings on February 27, 2024, followed by a conference call and webcast the next day. The company's board of directors has also declared a quarterly cash dividend of $0.30 per share of common stock, payable on February 29, 2024.
Positive
None.
Negative
None.
IRVINE, Calif.--(BUSINESS WIRE)--
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading.
A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The conference ID number is 1382596.
Also, on February 1, 2024, Sabra’s board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on February 29, 2024, to common stockholders of record as of the close of business on February 13, 2024.
About Sabra
Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.